Tilray Inc (Class 2) (TLRY)

$18.20USD

+$18.20 (+1,820.00%)

today (15 min delay)

About TLRY

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

CEO

Brendan Kennedy, MBA

Headquarters

Canada

Employees

688

Revenue (TTM)

136M

Gross Profit

32.55%

Earnings

Cash

$100M

Debt

$437M

TLRY related news

    Popular on Wealthsimple

      Investing on autopilot

      Invest in an intelligent portfolio of low-fee funds that are designed to meet your financial goals.

      • Low Fees - Pay an annual management fee of 0.50% (or 0.40% for accounts over $100K)

      • Stay on track - We'll instantly rebalance your portfolio and put your stock dividends back to work, earning you more

      • Human advice - We're loved for our technology. But we also have smart people to answer any questions or give advice when you need it.

      • Easy access - Manage your accounts from anywhere with our award-winning website and mobile app

      Clock

      Start investing in 5 minutes

      1. Answer a few questions about your goals and risk tolerance
      2. We'll recommend a portfolio that's right for you
      3. Connect your bank account and make a deposit

      Clicking get started accepts terms of use.